BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis
FRA:BAYN - DE000BAY0017 - Common Stock
28.155 EUR
-0.42 (-1.47%)
BAYN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 50 industry peers in the Pharmaceuticals industry. BAYN has a bad profitability rating. Also its financial health evaluation is rather negative. BAYN is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BAYN was profitable.
BAYN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BAYN reported negative net income in multiple years.
Each year in the past 5 years BAYN had a positive operating cash flow.
1.2 Ratios
BAYN has a worse Return On Assets (-3.25%) than 70.00% of its industry peers.
With a Return On Equity value of -11.25%, BAYN is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROIC | N/A |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BAYN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 54.95%, BAYN is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
BAYN's Gross Margin has declined in the last couple of years.
BAYN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BAYN remains at a similar level compared to 1 year ago.
BAYN has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, BAYN has an improved debt to assets ratio.
2.2 Solvency
BAYN has an Altman-Z score of 0.79. This is a bad value and indicates that BAYN is not financially healthy and even has some risk of bankruptcy.
BAYN's Altman-Z score of 0.79 is on the low side compared to the rest of the industry. BAYN is outperformed by 70.00% of its industry peers.
The Debt to FCF ratio of BAYN is 8.37, which is on the high side as it means it would take BAYN, 8.37 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.37, BAYN is doing worse than 60.00% of the companies in the same industry.
BAYN has a Debt/Equity ratio of 1.04. This is a high value indicating a heavy dependency on external financing.
BAYN has a worse Debt to Equity ratio (1.04) than 66.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Altman-Z | 0.79 |
ROIC/WACCN/A
WACC6.01%
2.3 Liquidity
A Current Ratio of 1.13 indicates that BAYN should not have too much problems paying its short term obligations.
BAYN has a Current ratio of 1.13. This is in the lower half of the industry: BAYN underperforms 72.00% of its industry peers.
A Quick Ratio of 0.73 indicates that BAYN may have some problems paying its short term obligations.
BAYN's Quick ratio of 0.73 is on the low side compared to the rest of the industry. BAYN is outperformed by 76.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.36%.
Measured over the past years, BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.27% on average per year.
The Revenue has decreased by -1.99% in the past year.
The Revenue has been growing slightly by 1.37% on average over the past years.
EPS 1Y (TTM)-16.36%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%30.85%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.63%
3.2 Future
Based on estimates for the next years, BAYN will show a small growth in Earnings Per Share. The EPS will grow by 3.03% on average per year.
Based on estimates for the next years, BAYN will show a small growth in Revenue. The Revenue will grow by 1.17% on average per year.
EPS Next Y-6.48%
EPS Next 2Y-1.54%
EPS Next 3Y2.06%
EPS Next 5Y3.03%
Revenue Next Year-1.14%
Revenue Next 2Y-0.12%
Revenue Next 3Y0.7%
Revenue Next 5Y1.17%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 5.62, which indicates a rather cheap valuation of BAYN.
94.00% of the companies in the same industry are more expensive than BAYN, based on the Price/Earnings ratio.
BAYN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.06.
A Price/Forward Earnings ratio of 5.75 indicates a rather cheap valuation of BAYN.
Based on the Price/Forward Earnings ratio, BAYN is valued cheaply inside the industry as 94.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.69. BAYN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.62 | ||
| Fwd PE | 5.75 |
4.2 Price Multiples
66.00% of the companies in the same industry are more expensive than BAYN, based on the Enterprise Value to EBITDA ratio.
BAYN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BAYN is cheaper than 98.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.02 | ||
| EV/EBITDA | 9.07 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.54%
EPS Next 3Y2.06%
5. Dividend
5.1 Amount
BAYN has a yearly dividend return of 0.39%, which is pretty low.
BAYN's Dividend Yield is slightly below the industry average, which is at 3.04.
With a Dividend Yield of 0.39, BAYN pays less dividend than the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
5.2 History
The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of BAYN are negative and hence is the payout ratio. BAYN will probably not be able to sustain this dividend level.
DP-3.69%
EPS Next 2Y-1.54%
EPS Next 3Y2.06%
FRA:BAYN (9/5/2025, 7:00:00 PM)
28.155
-0.42 (-1.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners41.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.66B
Analysts72.86
Price Target29 (3%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-3.69%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.87%
Min EPS beat(2)1.86%
Max EPS beat(2)45.89%
EPS beat(4)3
Avg EPS beat(4)8.47%
Min EPS beat(4)-17.26%
Max EPS beat(4)45.89%
EPS beat(8)6
Avg EPS beat(8)3.46%
EPS beat(12)8
Avg EPS beat(12)1.61%
EPS beat(16)12
Avg EPS beat(16)4.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-0.98%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)3
Avg Revenue beat(12)-2.37%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)0.39%
PT rev (3m)5.43%
EPS NQ rev (1m)-3.01%
EPS NQ rev (3m)19.4%
EPS NY rev (1m)2.38%
EPS NY rev (3m)2.38%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)-3.39%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-1.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.62 | ||
| Fwd PE | 5.75 | ||
| P/S | 0.6 | ||
| P/FCF | 6.02 | ||
| P/OCF | 3.87 | ||
| P/B | 0.91 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.07 |
EPS(TTM)5.01
EY17.79%
EPS(NY)4.9
Fwd EY17.39%
FCF(TTM)4.67
FCFY16.6%
OCF(TTM)7.28
OCFY25.85%
SpS47
BVpS30.91
TBVpS-18.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% | ||
| FCFM | 9.94% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score4
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Debt/EBITDA | 4.79 | ||
| Cap/Depr | 32.07% | ||
| Cap/Sales | 5.54% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 107.94% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 0.79 |
F-Score4
WACC6.01%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.36%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%30.85%
EPS Next Y-6.48%
EPS Next 2Y-1.54%
EPS Next 3Y2.06%
EPS Next 5Y3.03%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.63%
Revenue Next Year-1.14%
Revenue Next 2Y-0.12%
Revenue Next 3Y0.7%
Revenue Next 5Y1.17%
EBIT growth 1Y-161.08%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.3%
EBIT Next 3Y21.17%
EBIT Next 5Y10.77%
FCF growth 1Y1068.78%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y169.98%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%